MenB Vaccine: Implementation Via Information, Empowerment and Accessibility
- Conditions
- Meningococcal Vaccine
- Interventions
- Other: AwarenessOther: EducationOther: EmpowermentOther: Accessibility
- Registration Number
- NCT02975596
- Lead Sponsor
- University of Florida
- Brief Summary
As part of an effort to increase MenB vaccine uptake among adolescents and young adults, study teams will conduct qualitative research to maximize the effectiveness of nationally recommended MenB educational materials. In this study, Study Teams will assess local barriers to MenB vaccination by conducting focus groups with parents, students, and health care professionals.
- Detailed Description
Participants (parents of 16-23 year old teens and young adults, high school and college students 16-23 years old, and health care professionals for 16-23 year olds) will be asked to share their thoughts on the completeness of nationally recommended and publicly available MenB vaccine educational materials in addressing hesitations to receipt of the MenB vaccine. There is no risk in discussing reactions to educational materials. The biggest risk is disclosure of information provided in the study which will be reactions to health-promotion material.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1326
- Must be able to provide informed consent or assent
- Inability to provide informed consent or assent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Youth Awareness Youth between the ages beteen ages 13-18 will be offered awareness, education, empowerment and accessibility intervention components. Youth Accessibility Youth between the ages beteen ages 13-18 will be offered awareness, education, empowerment and accessibility intervention components. College Education Age between 18-23 will be offered awareness, education, empowerment and accessibility intervention components. Adult Education parents of adolescents and young adults will be offered awareness, education, and accessibility intervention components. Youth Education Youth between the ages beteen ages 13-18 will be offered awareness, education, empowerment and accessibility intervention components. Youth Empowerment Youth between the ages beteen ages 13-18 will be offered awareness, education, empowerment and accessibility intervention components. College Empowerment Age between 18-23 will be offered awareness, education, empowerment and accessibility intervention components. Adult Accessibility parents of adolescents and young adults will be offered awareness, education, and accessibility intervention components. College Awareness Age between 18-23 will be offered awareness, education, empowerment and accessibility intervention components. College Accessibility Age between 18-23 will be offered awareness, education, empowerment and accessibility intervention components. Adult Awareness parents of adolescents and young adults will be offered awareness, education, and accessibility intervention components.
- Primary Outcome Measures
Name Time Method Vaccine uptake in adolescents and young adults 12 months Percentage receiving MenB vaccine
Knowledge about MenB vaccine efficacy, potential benefits, possible side effects 12 months Percent of parents and young adults with Men B knowledge
- Secondary Outcome Measures
Name Time Method Attitudes re: Meningococcal B vaccine 12 months Pre- and Post- intervention surveys to assess attitudes, perceptions and decision-making re vaccine acceptance
Trial Locations
- Locations (6)
UF Health Pediatrics - Gerold L. Schiebler CMS Center
🇺🇸Gainesville, Florida, United States
UF Health Pediatrics - Tower Square
🇺🇸Gainesville, Florida, United States
University of Florida
🇺🇸Gainesville, Florida, United States
UF Family Medicine - Eastside
🇺🇸Gainesville, Florida, United States
UF Health Family Medicine and Pediatrics - Magnolia Parke
🇺🇸Gainesville, Florida, United States
UF Health Pediatric After Hours
🇺🇸Gainesville, Florida, United States